IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
Quick Stats
Jan 30, 202646.1
AI Score
HOLD0.09
Volume Ratio
Mar 04, 2026
Next Earnings
15
+ve Days (30d)
15
-ve Days (30d)
IOBT Stock Summary
Last updated Jan 30, 2026
IOBT is currently trading at $0.2901, positioned below its 200-day moving average of $1.14, suggesting bearish momentum. The stock has a 52-week range of $0.2053 to $2.79.
Technical Analysis: The 50-day moving average stands at $0.62, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 36.851, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.305, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates IOBT at 46.1/100 with a HOLD recommendation.
IOBT (IO Biotech, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 36.851 |
| CMF (20) | 0.305 |
| ROC (10) | -43.779 |
| ADX (14) | 33.85 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.099 |
| AROONOSC (14) | -50.0 |
| WILLAMS %R (14) | -77.871 |
| MFI (14) | 91.577 |
IOBT Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
IOBT Price vs Max Options Open Interest
IOBT Max Change In Options Open Interest
IOBT Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
IOBT Daily Out of Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
IOBT Daily In the Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
IOBT Most Active Options by Volume(near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
IO Biotech, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
IOBT Moving Averages Analysis
IOBT (IO Biotech, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 0.36 |
| 20 | 0.47 |
| 30 | 0.53 |
| 50 | 0.62 |
| 100 | 0.81 |
| 200 | 1.14 |
IOBT Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 22.8 million |
| Earnings/Share ($) | -1.34 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.88 |
| EPS Estimate Next Year ($) | -0.36 |
| WallStreet Target Price ($) | 2.18 |
| Most Recent Quarter |